EP3317403
OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.6.2016EP published:
5.3.2025EP application number:
16818706.0
EPO information:
European Patent Register
Max expiry date:
28.6.2036
Title in English:
OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSELanguage of the patent:
English
Timeline
Today
29.6.2016EP application
5.3.2025EP Publication
Owner
Name:
NorthWest Biotherapeutics, Inc.Address:
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814, US
Inventor
Name:
BOSCH, Marnix, L.Address:
Medina, WA 98039, US
Priority
Number:
201562187086 PDate:
30.6.2015Country:
US
Classification
Categories:
C12N 5/0784, C12N 5/24, A61P 35/00, A61K 39/00, A61K 35/14